Developing and validation a prognostic model for predicting prognosis among synchronous colorectal cancers patients using combined log odds ratio of positive lymph nodes: a SEER database study
BMC Gastroenterology · 2024
DOI: 10.1186/s12876-024-03393-7 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Yue Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Northern Jiangsu People's Hospital, Clinical Teaching Medical School of Nanjing University, No.98 Nantong Wes…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Nomograms, SEER Program, Neoplasms, Multiple Primary. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The research was sponsored by Key Laboratory of Basic and Clinical Transformation of Digestive /Metabolic Diseases of Yangzhou City.
Abstract (Originalsprache)
PURPOSE: The aim of the study is to identify risk factors for the prognosis and survival of synchronous colorectal cancer and to create and validate a functional Nomogram for predicting cancer-specific survival in patients with synchronous colorectal cancer. METHODS: Synchronous colorectal cancers cases were retrieved from the Surveillance, Epidemiology, and End Results database retrospectively, then they were randomly divided into training (n = 3371) and internal validation (n = 1440) sets, and a set of 100 patients from our group was used as external validation. Risk factors for synchronous colorectal cancer were determined using univariate and multivariate Cox regression analyses, and two Nomograms were established to forecast the overall survival and cancer-specific survival, respectively. We assessed the Nomogram performance in terms of discrimination and calibration. Bootstrap resampling was used as an internal verification method, and we select external data from our hospital as independent validation sets. RESULTS: Two Nomograms are established to predict the overall survival and cancer-specific survival. In OS Nomogram, sex, age, marital status, ttumor pathological grade, AJCC TNM stage, preoperative serum CEA level, LODDS, radiotherapy and chemotherapy were determined as prognostic factors. In CSS Nomogram, age and marital status, AJCC TNM stage, tumor pathological grade, preoperative serum CEA level, LODDS, radiotherapy and chemotherapy were determined as prognostic factors.The C-indexes for the forecast of overall survival were 0.70, and the C-index was 0.68 for the training and internal validation cohort, respectively. The C-indexes for the forecast of cancer-specific survival were 0.75, and the C-index was 0.74 for the training and internal validation cohort, respectively. The Nomogram calibration curves showed no significant deviation from the reference line, indicating a good level of calibration. Both C-index and calibration curves indicated noticeable performance of newly established Nomograms. CONCLUSIONS: Those Nomograms with risk rating system can identify high risk patients who require more aggressive therapeutic intervention and longer and more frequent follow-up scheme, demonstrated prognostic efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Northern Jiangsu People's Hospital, Clinical Teaching Medical School of Nanjing University, No.98 Nantong West Road, Yangzhou, Jiangsu Province, 225001, China.
- Medical College of Yangzhou University, Yangzhou, 225001, China.
- Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China.
- General Surgery Institute of Yangzhou, Yangzhou University, Yangzhou, 225001, China.
- Yangzhou Key Laboratory of Basic and Clinical Transformation of Digestive and Metabolic Diseases, Yangzhou, 225001, China.
- Department of Gastrointestinal Surgery, Northern Jiangsu People's Hospital, Clinical Teaching Medical School of Nanjing University, No.98 Nantong West Road, Yangzhou, Jiangsu Province, 225001, China. wdaorong666@sina.co…
Förderung
- The research was sponsored by Key Laboratory of Basic and Clinical Transformation of Digestive /Metabolic Diseases of Yangzhou City
Zitieren
APA
Ma, Y., Chen, B., Fu, Y., Ren, J., & Wang, D. (2024). Developing and validation a prognostic model for predicting prognosis among synchronous colorectal cancers patients using combined log odds ratio of positive lymph nodes: a SEER database study. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03393-7
Vancouver
Ma Y, Chen B, Fu Y, Ren J, Wang D. Developing and validation a prognostic model for predicting prognosis among synchronous colorectal cancers patients using combined log odds ratio of positive lymph nodes: a SEER database study. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03393-7
BibTeX
@article{Ma2024,
author = {Ma, Yue and Chen, Bangquan and Fu, Yayan and Ren, Jun and Wang, Daorong},
title = {Developing and validation a prognostic model for predicting prognosis among synchronous colorectal cancers patients using combined log odds ratio of positive lymph nodes: a SEER database study},
journal = {BMC Gastroenterology},
year = {2024},
doi = {10.1186/s12876-024-03393-7}
}
EUVIMED